Vanderbilt University Medical Center is searching for 220 volunteers who recently tested positive for coronavirus for a new clinical trial of drugs with potential to treat the virus. Participants will be joining a nationwide “ACTIVE-2” clinical trial, of which Vanderbilt is one of 25 test sites. This therapeutic drug trial is separate from coronavirus vaccine trials that are ongoing at Vanderbilt and elsewhere in Nashville.
